OSCR vs. ESGR, UBSI, AEL, VNO, PFSI, FFIN, AGO, LAZ, KRG, and SLM
Should you be buying Oscar Health stock or one of its competitors? The main competitors of Oscar Health include Enstar Group (ESGR), United Bankshares (UBSI), American Equity Investment Life (AEL), Vornado Realty Trust (VNO), PennyMac Financial Services (PFSI), First Financial Bankshares (FFIN), Assured Guaranty (AGO), Lazard (LAZ), Kite Realty Group Trust (KRG), and SLM (SLM). These companies are all part of the "finance" sector.
Enstar Group (NASDAQ:ESGR) and Oscar Health (NYSE:OSCR) are both mid-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings, valuation and community ranking.
Enstar Group has a net margin of 77.65% compared to Enstar Group's net margin of -0.82%. Oscar Health's return on equity of 18.33% beat Enstar Group's return on equity.
81.0% of Enstar Group shares are owned by institutional investors. Comparatively, 75.7% of Oscar Health shares are owned by institutional investors. 7.2% of Enstar Group shares are owned by company insiders. Comparatively, 25.5% of Oscar Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
In the previous week, Oscar Health had 11 more articles in the media than Enstar Group. MarketBeat recorded 17 mentions for Oscar Health and 6 mentions for Enstar Group. Oscar Health's average media sentiment score of 1.09 beat Enstar Group's score of 0.43 indicating that Enstar Group is being referred to more favorably in the media.
Enstar Group received 214 more outperform votes than Oscar Health when rated by MarketBeat users. Likewise, 65.85% of users gave Enstar Group an outperform vote while only 53.70% of users gave Oscar Health an outperform vote.
Oscar Health has a consensus price target of $15.00, suggesting a potential downside of 33.77%. Given Enstar Group's higher possible upside, analysts plainly believe Oscar Health is more favorable than Enstar Group.
Enstar Group has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Enstar Group, indicating that it is currently the more affordable of the two stocks.
Enstar Group has a beta of 0.67, meaning that its share price is 33% less volatile than the S&P 500. Comparatively, Oscar Health has a beta of 1.66, meaning that its share price is 66% more volatile than the S&P 500.
Summary
Enstar Group beats Oscar Health on 11 of the 17 factors compared between the two stocks.
Get Oscar Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for OSCR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OSCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oscar Health Competitors List
Related Companies and Tools
